Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data
Patrick M Dillon,1 Christiana M Brenin,1 Craig L Slingluff Jr2 1University of Virginia, Division of Hematology/Oncology, Charlottesville, VA 22908, USA; 2University of Virginia, Department of Surgery, Charlottesville, VA 22908, USACorrespondence: Patrick M DillonDivision of Hematology/Oncology, Univ...
Main Authors: | Dillon PM, Brenin CM, Slingluff CL Jr |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | Breast Cancer : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/evaluating-nelipepimut-s-in-the-treatment-of-breast-cancer-a-short-rep-peer-reviewed-article-BCTT |
Similar Items
-
A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer
by: Patrick M. Dillon, et al.
Published: (2017-11-01) -
Murine Dendritic Cells Grown in Serum-Free Culture Show Potent Therapeutic Activity when Loaded with Novel Th Epitopes in an Orthotopic Model of HER2<sup>pos</sup> Breast Cancer
by: Loral E. Showalter, et al.
Published: (2021-09-01) -
Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer
by: Sandeep Pallerla, et al.
Published: (2021-01-01) -
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
by: Jagosky M, et al.
Published: (2021-06-01) -
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
by: E. Krasniqi, et al.
Published: (2019-10-01)